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ABSTRACT
Background Since 2007, New York City’s primary care
information project has assisted over 3000 providers to
adopt and use a prevention-oriented electronic health
record (EHR). Participating practices were taught to re-
adjust their workﬂows to use the EHR built-in population
health monitoring tools, including automated quality
measures, patient registries and a clinical decision
support system. Practices received a comprehensive
suite of technical assistance, which included quality
improvement, EHR customization and conﬁguration,
privacy and security training, and revenue cycle
optimization. These services were aimed at helping
providers understand how to use their EHR to track and
improve the quality of care delivered to patients.
Materials and Methods Retrospective electronic chart
reviews of 4081 patient records across 57 practices
were analyzed to determine the validity of EHR-derived
quality measures and documented preventive services.
Results Results from this study show that workﬂow
and documentation habits have a profound impact on
EHR-derived quality measures. Compared with the
manual review of electronic charts, EHR-derived
measures can undercount practice performance, with
a disproportionately negative impact on the number of
patients captured as receiving a clinical preventive
service or meeting a recommended treatment goal.
Conclusion This study provides a cautionary note in
using EHR-derived measurement for public reporting of
provider performance or use for payment.
The American Recovery and Reinvestment Act of
2009 authorized US$19 billion in funding for the
deployment and meaningful use of electronic
health records (EHR), and introduced a national
framework for the adoption of health information
technology.
1 The Center for Medicare and Medicaid
Services has offered eligible providers ﬁnancial
incentives for demonstrating meaningful use of
EHR and reporting on the quality of care.
2 Starting
with stage 1 of meaningful use, the Center for
Medicare and Medicaid Services calls for the
submission of provider-level quality measures,
initially by attestation but then through electronic
submission, starting as early as 2012. Many stake-
holders, including payers, independent physician
associations, and consumers have a vested interest
in accessing and utilizing EHR-derived quality
measures for purposes of accountability or rank-
ings. However, quality measures derived from EHR
have yet to be validated as representative of
provider performance for incentives or comparative
purposes.
Unlike most claims-based quality measurement,
measures derived from EHR can incorporate clinical
ﬁndings, allowing for the tracking of intermediate
outcomes such as blood pressure and body mass
index. However, documentation habits by providers
can vary, and the necessary data entered into the
EHR may not be interpreted or recognized by
standard EHR software programming. This may
lead to undercounting the patients eligible for
a preventive service (eg, diagnosis of ischemic
cardiovascular disease) or receiving a recommended
treatment (eg, screening or medication) or meeting
a recommended target (eg, control of blood pressure
to less than 140/90 mm Hg).
Formed in 2005, the New York City Primary Care
Information Project (PCIP) has assisted over 3000
providers to adopt and use a prevention-oriented
EHR as a means to improve the delivery of primary
care. Nearly 40% of the participating providers are
operating in small (fewer than 10 providers),
physician-owned practices. PCIP selected an EHR
vendor through a competitive process and co-
developed prevention-oriented functionality and
population health monitoring tools, including
automated quality reporting and a clinical decision
support system (CDSS). The quality reporting tool
displays by measure, for each eligible patient,
whether the practice has or has not met the
recommended preventive service. In addition, at
the point of care, the CDSS function displays the
preventive services a patient is eligible for and has
not yet received, allowing the provider to take
action (eg, order a mammogram, adjust medications,
discuss smoking cessation aids) during the visit.
Providers were trained by both the EHR vendor’s
training staff and practice consultants employed by
PCIP, who provided on-site technical assistance.
Providers were taught to re-adjust the practice’s
workﬂows to document diagnoses and key
preventive services in structured ﬁelds that are
searchable and capable of generating the quality
measures and preventive service reminders.
Providers were also shown how to view their EHR
calculated quality measures both within the EHR
and through monthly reports generated by PCIP
staff and emailed to individual providers. In addi-
tion, efforts were made to create alignment
between payment and improved quality of care by
informing providers of the various available incen-
tive programmes as well as launching PCIP
designed programmes. Through these synergistic
changes: (1) prevention-oriented EHR; (2) practice
workﬂow redesign; and (3) payment that rewards
prevention, PCIP worked with primary care
providers to prioritize prevention and facilitate
management of chronic disease.
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Research and applicationsinformation entered into the EHR and describes the issues
contributing to variations in the results of automated EHR
quality measurement.
METHODS
Practice selection
A subset of 82 practices enrolled in a pilot rewards and recog-
nition programme were invited to participate in the data vali-
dation study, as they had all implemented the eClinicalWorks
EHR software before January 2009 and received technical
assistance through the PCIP programme, and had a majority of
their patient panel recorded in the EHR. Practices were required
to have a minimum of 200 electronic patient records with
a diagnosis of diabetes, hypertension, dyslipidemia, or ischemic
cardiovascular disease. All 82 practices received a software
upgrade between February and August 2009 to implement
automated quality measurement reporting and the CDSS func-
tionality. Participating practices signed a letter of consent
allowing independent medical reviewers to conduct abstraction
of the EHR and received an honorarium of US$500 for
completing the study. This study was approved by the
Department of Health and Mental Hygiene institutional review
board no 09-067.
Electronic chart reviews
Medical reviewers randomly sampled 120 electronic patient
charts per practice for established patients between 18 and
75 years of age, with at least one ofﬁce visit since the practice
implemented the EHR. For this study, data from the manual
review of the electronic chart (e-chart) were analyzed if the
patient had an ofﬁce visit during the 6-month period after the
activation date of the quality measurement reporting tool and
implementation of the CDSS.
For each e-chart, reviewers abstracted the patient’s age and
gender, along with vitals, diagnoses, medications, laboratory
results, diagnostic images, vaccinations, and receipt of or referral
to counselling for the most recent visit. Depending on the data
element, reviewers were instructed to search in multiple loca-
tions of the EHR: problem list, medical history, social history,
progress notes (chief complaint, history of present illness,
assessment), procedures, diagnostic images, vitals, and laboratory
tests. Each reviewer was trained and tested by a standardized
approach to ensure interrater reliability. If there was uncertainty
whether documentation would meet the quality measure
criteria a senior reviewer and PCIP staff would determine
whether to include or exclude the observation.
Analytical methods
For each patient, each data element was coded based on whether
it was documented in a structured ﬁeld recognized by the
existing EHR software for automated quality measurement
(1¼location recognized and 0¼not recognized for quality
measurement reporting). In addition, two sets of numerator and
denominator counts were generated for each of the 11 quality
measures. The ﬁrst set of counts included only those patients
whose information was documented in structured ﬁelds recog-
nized by the existing software (EHR automated). The second set
of counts incorporated all information about patients docu-
mented in the EHR (e-chart review). Data element coding and
all counts were calculated using Microsoft Access structured
query language.
Simple frequencies and descriptive statistics were generated to
determine data element documentation patterns and estimate
population-level numerators and denominators for each quality
measure. Wilcoxon non-parametric tests were used to compare
practice-level numerators and denominators calculated for each
measure.
All descriptive statistics and tests were conducted using SAS
V.9.2 analytical software. Practice distribution of documentation
and calculated proportions of elements documented in various
locations of the electronic chart were generated in MS Excel and
MS Access.
RESULTS
Of the 82 practices eligible for the study, 57 practices agreed to
allow PCIP to conduct the e-chart review. Based on self-reported
information and practice registries, practices that agreed to
participate in the study had a higher average percentage of
Medicaid insured patients (42.7% vs 30.7%), and a higher number
of patients with diabetes (209.9 vs 110.0) and hypertension
(477.8 vs 353.2) (table 1).
A total of 4081 e-charts was available for this analysis. An
additional 2759 e-charts were reviewed, but were excluded from
the analysis because the patients did not have a qualifying ofﬁce
visit during the 6-month study period. More than half of the
ﬁnal study sample of patients were women (59.4%), and the
average patient age was 48.1 years. Participating practices varied
in their distribution of patients with diagnoses of diabetes,
ischemic cardiovascular disease, hypertension, dyslipidemia and
patients who were current smokers (table 1). The majority
(89.9%) of participating providers were primary care providers
(ie, internal medicine, family medicine, pediatrics, obstetrics/
gynecology). Non-primary care providers specialized in cardi-
ology, pulmonology, endocrinology, allergy, gastroenterology, or
did not specify a specialty (data not shown).
We looked across the 11 clinical quality measures to assess
where information was documented. The presence of data
recognized for automated quality measurement varied widely,
ranging from 10.7% to 99.9% (table 2). Measure components
Table 1 Characteristics of practices and patient charts reviewed
Participating
in chart
review (N[57)
Not participating
in chart
review (N[28)
Mean (minLmax) Mean (minLmax)
Practice characteristics
No of providers per practice 2.9 (1 24) 2.4 (1 13)
No of full-time equivalent 1.7 (0.7 9.2) 1.9 (1.0 10.8)
Percentage of patients with
Medicaid insurance or uninsured
42.7 (0.0 90.0) 30.7 (2.0 81.0)
Estimated population*
Patients >18 years of age with at
least one ofﬁce visit in the past year
1936.2 (0 9117) 1905.5 (12 9723)
Diabetes 209.9 (3 1480) 110.0 (1 450)
Hypertension 477.8 (2 2460) 353.2 (1 1121)
Months using EHR by 1 July 2009 14.3 (7.5 39.1) 13.7 (3.7 22.4)
Mean (Min   Max) Not applicable
Patient characteristics of charts reviewed
Medical charts reviewed (total 4081) 71.6 (19 111) e
%Female 59.4 (35.0 80.7) e
Patient age, years 48.1 (32.8 61.5) e
Percentage of records with diagnoses
Diabetes 17.6 (0.0 48.1) e
Ischemic cardiovascular disease 7.3 (0.0 39.0) e
Hypertension 41.2 (8.2e87.0) e
Dyslipidemia 36.0 (3.3 85.4) e
Current smokers 10.3 (1.4 37.9) e
*From automated reporting from the electronic health record (EHR)dseparate from
electronic chart reviews.
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Research and applicationsTable 2 Frequency of clinical information and locations in electronic charts for quality measurement
Name of measure and brief description
Description of denominator
(D) or numerator (N) data element
(no of eligible charts)
Recognized for quality
measurement
Not recognized for quality
measurement
Location No % Location No %
Screening measures (patients for the denominator are identiﬁed by their age and gender)
Breast cancer screening
Female patients $40 years of age
who received a mammogram in the
past 2 years
N Diagnostic order and result for
mammogram (543)
Procedures 29 10.7 Scanned patient docs 270 48.7
Diagnostic imaging 204 36.8
Other 10 3.6
BMI
Patients $18 years of age who have
a BMI measured in the past 2 years
N BMI documented (3122) Vitals 3116 99.8 Medical history 2 0.1
Other 4 0.1
Inﬂuenza vaccine
Patients >50 years of age who
received a ﬂu shot in the past year
N Inﬂuenza vaccination documented (480) Immunizations 475 99.0 Chief complaint/HPI 3 0.6
Procedures 2 0.4
Smoking status
Smoking status updated annually
in patients $18 years of age
N Smoking status documented (3357) Smart form 1796 53.4 Social history 1530 45.5
Other 26 0.8
Medical history 5 0.2
Intervention measures
Antithrombotic therapy
Patients $18 years of age with
a diagnosis of IVD or $40 years
of age with a diagnosis of
diabetes taking aspirin or
another antithrombotic therapy
D Diabetes diagnosis and age
$40 years (680)
Problem list 623 91.6 Medical history 42 6.2
Assessment 11 1.6
Chief complaint/HPI 4 0.6
D IVD diagnosis (303) Problem list 250 82.5 Medical history 45 14.9
Assessment 7 2.3
Chief complaint/HPI 1 0.3
N Appropriate medication prescribed (759) Medications 757 99.7 Plan/treatment 2 0.3
BP control
Patients 18e75 with a diagnosis of
hypertension, with or without IVD,
with a recorded systolic BP
<140 mm Hg and diastolic BP
<90 mm Hg in the past 12 months
(<130 mm Hg and 80 mm Hg in
patients with hypertension and DM)
D Hypertension diagnosis (1676) Problem list 1497 89.3 Medical history 157 9.4
Assessment 11 0.7
Chief complaint/HPI 11 0.7
Comorbid diagnoses
D Diabetes (551) Problem list 512 92.9 Medical history 28 5.1
Assessment 10 1.8
HPI 1 0.2
D IVD (118) Problem list 93 78.8 Medical history 24 20.3
Assessment 1 0.9
N BP documented (3868) Vitals 3866 99.9 Medical history 2 0.1
Cholesterol screening and control D Dyslipidemia diagnosis (1468) Problem list 1112 75.1 Medical history 269 18.2
Assessment 86 5.8
Chief complaint/HPI 12 0.8
High risk
Screening: Patients 18e75 years
of age with a diagnosis of
dyslipidemia and DM or IVD with
a measured LDL in the past year
Comorbid diagnoses
D Diabetes (515) Problem list 477 92.6 Medical history 30 5.8
Assessment 6 1.2
Chief complaint/HPI 2 0.4
Control: Screened patients with
LDL <100 mg/dl
D IVD (211) Problem list 182 86.3 Medical history 27 12.8
Assessment 1 0.5
Chief complaint/HPI 1 0.5
General population
Screening: M 35+, F45+ w/no
DM/IVD with a measured total
cholesterol or LDL in the past
5 years
N LDL cholesterol test result (2425) Laboratory tests 1294 53.4 Scanned patient docs 1106 45.6
Other 24 1.0
Medical history 1 0.0
Control: Screened patients with
total cholesterol <240 mg/dl or
LDL <160 mg/dl
N Total cholesterol test result (2545) Laboratory tests 1383 53.4 Scanned patient docs 1137 44.7
Other 24 0.9
Medical history 1 0.0
Hemoglobin A1c screening and control
Screening: Patients 18e75 years
of age with a diagnosis of DM with
a documented hemoglobin A1c test
within the past 6 months
D Diabetes diagnosis (740) Problem list 676 91.4 Medical history 48 6.5
Assessment 12 1.6
Chief complaint/HPI 4 0.5
Control: Screened patients with
hemoglobin A1c <7%
N Hemoglobin A1c test result (642) Laboratory tests 294 63.0 Scanned patient docs 171 36.6
Other 2 0.4
Continued
606 J Am Med Inform Assoc 2012;19:604e609. doi:10.1136/amiajnl-2011-000557
Research and applicationsrelying on vitals, vaccinations, and medications had the highest
proportion of information documented in structured ﬁelds
recognized by the automated quality measures. The majority
of diagnoses for chronic conditions such as diabetes (>91.4%
across measures), hypertension (89.3%), ischemic cardiovascular
disease (>78.8% across measures) and dyslipidemia (75.1%) were
documented in the problem list, a structured ﬁeld used for
automated quality measurement. Patient diagnoses not recog-
nized for inclusion in the measure were recorded in the medical
history, assessment, chief complaint, or history of present
illness, sections that typically allow for free-text entries.
Diagnostic orders or results for mammogram had the lowest
proportion (10.7%) of data recorded in structured ﬁelds recog-
nized for automated quality measurement. The majority of the
information for breast cancer screening was found as scanned
patient documents and diagnostic imaging; both sources of
information are not amenable for automated electronic queries.
Nearly half of the information for measures that require
a laboratory test result, such as control of hemoglobin A1c and
cholesterol, was documented in structured ﬁelds recognized for
automated quality measurement (range 53.4e63.0%). Similarly,
only half of the information regarding patient smoking status
(53.4%) was recognized for automated quality measurement.
With the exception of medications, vaccinations, and blood
pressure readings, practices varied substantially in where they
chose to document the data elements required for automated
quality measurement (ﬁgure 1).
In estimating the denominator loss due to unrecognizable
documentation, the average practice missed half of the eligible
patients for three of the 11 quality measuresdhemoglobin A1c
control, cholesterol control, and smoking cessation intervention
(table 3). No statistically signiﬁcant differences were observed
between the e-chart and EHR automated quality measurement
scores in the number of patients captured for the denominator
for the remaining eight measures. Current EHR reporting would
underreport practice numerators for six of the 11 measuresd
hemoglobin A1c control, hemoglobin A1c screening, breast
cancer screening, cholesterol control, cholesterol screening, and
smoking status recorded.
DISCUSSION
As the nation continues to drive EHR adoption through signiﬁcant
infusions of funding for health information technology infra-
structure and support, and payment reform carries the promise of
improved quality at lower cost, it is important and timely to
assess the validity of EHR-derived clinical quality measures.
Table 2 Continued
Name of measure and brief description
Description of denominator
(D) or numerator (N) data element
(no of eligible charts)
Recognized for quality
measurement
Not recognized for quality
measurement
Location No % Location No %
Smoking cessation intervention
Current smokers who received
cessation interventions or
counselling in the past 12 months
D Documented current smokers (409) Smart form 243 59.4 Social history 161 39.4
Other 3 0.7
Assessment 2 0.5
N Smoking cessation intervention (129) Smart form 85 64.9 Other 33 25.2
Medications 8 6.1
Scanned patient docs 3 2.3
BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HPI, history of present illness; IVD, ischemic cardiovascular disease; LDL, low-density lipoprotein.
Figure 1 Distribution of
documentation and data elements
recognized for quality measurement
across 57 practices. EHR, electronic
health record; IVD, ischemic
cardiovascular disease; LDL,
low-density lipoprotein.
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majority of patients are documented in structured ﬁelds needed
for automated quality reporting and point-of-care reminders,
and that there is not a signiﬁcant amount of ‘denominator loss’
when using EHR-derived measurement versus e-chart reviews.
However, EHR-derived quality measurement can result in
signiﬁcant numerator loss, resulting in underestimates of the
delivery of clinical preventive services.
It is important to understand the impact of workﬂows and
documentation habits on EHR-derived quality measures. In this
study, the majority of practices correctly documented diagnoses
of hypertension and diabetes over 80% of the time, but rates of
appropriate documentation for dyslipidemia and ischemic
cardiovascular disease were substantially lower. Providers may be
more likely to overlook chronic diseases that are documented
elsewhere in the chart, a ﬁnding we commonly see in the case of
obesity and active smoking. Anecdotally, providers have reported
to us that they limit the number of assessments assigned to
a patient at any given visit due to the historical limitation related
to paper claims (some payers limit the number of assessments
that can be reported in paper claims to four or fewer), which may
have the unintended consequence of ‘underdocumentation’.
For laboratory tests, the presence or absence of laboratory
interfaces and the appropriate logical observation identiﬁers
names and codes creates signiﬁcant variation in practice scores.
Even if a practice has an electronic interface, reference labora-
tories do not consistently provide EHR vendors with compen-
diums that have logical observation identiﬁers names and codes
codes for each test, and therefore, some test orders and results
remain undetected by EHR software. For practices with no
electronic laboratory interface, the quality measures that rely on
laboratory data can only be addressed by manually entering the
results into structured ﬁelds, which few providers do.
In addition, for quality measures that rely on tests or procedures
performed in a different ofﬁce setting, the difﬁculty of getting the
results back, and in structured form, makes it challenging to
satisfy those measures. In this study, the mammography quality
measure was only satisﬁed by the presence of a structured test
result, yet most mammography results come back in the form of
faxed results, necessitating an additional step by the practice to
codify the results in structured form. Eventually, developments in
natural language processing may help convert unstructured text
results into their structured counterparts needed to satisfy quality
measures and trigger clinical decision support.
Finally, some quality measures may be impacted by incorrect
or imprecise logic used to code the measure. For instance, with
mammography rates, the relatively low practice performance
seen in this study is largely attributable to a speciﬁc ﬂaw in the
design of the EHR’s quality measure. For over a year, this
particular measure would only allow a mammogram result to
satisfy the measure if the results were structured and the test
was ordered as a ‘procedure’, and not a ‘diagnostic image’, the
latter being the more consonant with provider preference.
Providers uniformly scored well on documentation of aspirin
therapy, inﬂuenza vaccination and blood pressure, probably due
to the relative lack of options in the EHR to document these
data in ﬁelds other than the designated locations. For some other
measures, such as smoking status, documentation can vary
widely provider to provider, including a variety of notations (eg,
‘+ smoker’, ‘+ cig’, ‘2 ppd’, ‘smoker’, and ‘+ tobacco’) and
locations (eg, smart form, preventive medicine, social history).
This variability in documentation preference has been shown to
lead to signiﬁcant variations in quality measurement depending
on which ﬁelds are chosen and how much granularity is
provided. The bimodal distribution of practice documentation
for smoking status is probably due to the difference in whether
practices used the structured ﬁelds in the smart form to satisfy
the quality measure.
This study has several limitations. Several practices refused to
participate in the chart review. The majority that did not
participate stated they lacked sufﬁcient physical space for the
chart reviewers to conduct their reviews. Practices electing not
to participate in the study did not differ in their population
characteristics, as shown in table 1. This study also limited its
chart reviews to practices that were using eClinicalWorks;
therefore, the ﬁndings may not be generalizable to other EHR. In
addition, the study focused on available documentation in the
electronic record, and we did not conduct an audit of whether
providers or practice staff actually delivered the services
recorded. Separate studies will need to be conducted to ascertain
whether information recorded in the EHR may not reﬂect the
actual care delivered.
Finally, this study did not assess how practice characteristics,
interventions by PCIP, or the use of speciﬁc EHR functionality
may have impacted differences in documentation variation.
These studies are being conducted separately.
Until recently, quality measures were largely derived from
manual paper chart reviews, secondary analysis of claims
Table 3 Comparison of numerator and denominator counts for EHR automated quality measurement and
electronic chart review (n¼57 practices)
Measure
Denominator Numerator
EHR query e-Chart review EHR query e-Chart review
Mean SD Mean SD Mean SD Mean SD
A1c control 4.9 5.2 8.2** 6.1 1.8 2.4 2.7* 2.6
A1c screening 11.8 8.6 12.9 8.6 4.9 5.2 8.2** 6.1
Antithrombotic therapy 13.1 10.3 14.7 10.6 7.5 7.8 8.2 7.8
Body mass index 71.4 18.1 71.4 18.1 54.6 23.2 54.8 23.2
Blood pressure control 25.7 14.4 29.3 14.4 14.1 9.6 16.2 10.0
Breast cancer screening 28.7 9.9 28.7 9.9 1.0 2.3 9.5** 8.2
Cholesterol control 15.7 14.3 29.1** 15.7 13.0 12.5 23.8** 13.5
Cholesterol screening 41.7 15.2 44.2 15.8 15.7 14.3 29.1** 15.7
Inﬂuenza vaccination 34.4 15.1 34.4 15.1 8.1 8.7 8.3 8.9
Smoking cessation intervention 4.3 3.8 7.2** 4.8 1.5 2.7 2.3 3.5
Smoking status recorded 71.5 18.1 71.5 18.1 31.5 24.0 59.5** 18.9
*p<0.01 **p<0.001.
EHR, electronic health record.
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Research and applicationsdatabases, or patient surveys, as opposed to being calculated
from EHR derived data. This was driven in large part by the
historically low rates of EHR use nationwide and the ensuing
lack of data availability, quality, and comparability. Studies
comparing claims data with clinical data have noted signiﬁcant
disparities between the two sources,
4 5 yet claims-based quality
measurement has continued to be the dominant form of large-
scale quality analysis because no other data sources have been
readily available either as a complement or replacement. In some
measures, such as breast cancer screening, the use of adminis-
trative or claims data may still be more reliable until health
information exchanges are established, more broadly adopted,
and can integrate multiple data sources to establish more
comprehensive measures on recommended care delivery and
health outcomes.
EHR offer new potential for performance measurement given
that most commercially available EHR use standard dictionaries
to capture information in coded forms, such as ICD for problem
list and SNOMED for medications. Using these codiﬁed data,
EHR can help identify patient populations and calculate
a signiﬁcant number of quality measures that leverage data
available in the EHR.
6 These measures can range from adherence
to clinical guidelines to assessments of rates of clinical preven-
tive services to rates of screening. However, EHR-derived quality
measurement has limitations due to several factors, most
notably variations in EHR content, structure and data format, as
well as local data capture and extraction procedures.
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Several steps can be taken to mitigate the variability of EHR
documentation. As part of PCIP’s programme, providers are
trained on proper documentation techniques during their initial
EHR training, and then quality improvement specialists rein-
force their use, but ultimately there are no mechanisms to force
providers to document in a particular location in the chart.
Providers need regular prompts, training and feedback to alter
their documentation habits. Studies have shown that clinical
decision support can help improve the quality and accuracy of
documentation.
9 Another way to mitigate the variability of
documentation would be to include claims data to populate the
EHR, thereby providing a more robust and complete proﬁle of
the patient. In addition, standards need to be developed for what
needs to be documented in the various medical record compo-
nents, such as a clinical encounter note or a care plan document.
Much work is being done to standardize the output of EHR for
use in health information exchange (eg, the continuity of care
document), but few efforts are aimed at standardizing what
data inputs should go into the EHR.
More studies are needed to assess the validity of EHR-derived
quality measures and to ascertain which measures are best
calculated using claims or administrative data or a combination
of data sources. If provider-speciﬁc quality measurements are to
be reported and made public, as is the plan for the meaningful
use quality measures, further analysis is needed to understand
the limitations of these data, particularly if they are prone to
underestimation of true provider performance.
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